Clinical Pharmacology in Sleep Medicine
Joint Authors
Proctor, Ashley
Bianchi, Matt T.
Source
Issue
Vol. 2012, Issue 2012 (31 Dec. 2012), pp.1-14, 14 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2012-11-14
Country of Publication
Egypt
No. of Pages
14
Main Subjects
Pharmacy, Health & Medical Sciences
Pharmacology
Abstract EN
The basic treatment goals of pharmacological therapies in sleep medicine are to improve waking function by either improving sleep or by increasing energy during wakefulness.
Stimulants to improve waking function include amphetamine derivatives, modafinil, and caffeine.
Sleep aids encompass several classes, from benzodiazepine hypnotics to over-the-counter antihistamines.
Other medications used in sleep medicine include those initially used in other disorders, such as epilepsy, Parkinson’s disease, and psychiatric disorders.
As these medications are prescribed or encountered by providers in diverse fields of medicine, it is important to recognize the distribution of adverse effects, drug interaction profiles, metabolism, and cytochrome substrate activity.
In this paper, we review the pharmacological armamentarium in the field of sleep medicine to provide a framework for risk-benefit considerations in clinical practice.
American Psychological Association (APA)
Proctor, Ashley& Bianchi, Matt T.. 2012. Clinical Pharmacology in Sleep Medicine. ISRN Pharmacology،Vol. 2012, no. 2012, pp.1-14.
https://search.emarefa.net/detail/BIM-507653
Modern Language Association (MLA)
Proctor, Ashley& Bianchi, Matt T.. Clinical Pharmacology in Sleep Medicine. ISRN Pharmacology No. 2012 (2012), pp.1-14.
https://search.emarefa.net/detail/BIM-507653
American Medical Association (AMA)
Proctor, Ashley& Bianchi, Matt T.. Clinical Pharmacology in Sleep Medicine. ISRN Pharmacology. 2012. Vol. 2012, no. 2012, pp.1-14.
https://search.emarefa.net/detail/BIM-507653
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-507653